GNS Co-Founder and CEO Colin Hill joined the ChasmPartners Roundtable to discuss the innovative approaches leveraging data and analytics being applied to drug development with Miki Kapoor, CEO of Verana Health, and Ken Tarkoff, CEO of Syapse. The conversation covered recent acquisitions in the data and analytics market, the evolving role of big data and artificial intelligence in biotech and precision medicine, and the current challenges facing AI industry players. Read the full interview here.